vs
Side-by-side financial comparison of Laird Superfood, Inc. (LSF) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.
SS Innovations International, Inc. is the larger business by last-quarter revenue ($14.5M vs $13.3M, roughly 1.1× Laird Superfood, Inc.). Laird Superfood, Inc. runs the higher net margin — -13.2% vs -17.0%, a 3.8% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs 15.0%). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 16.1%).
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.
LSF vs SSII — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $14.5M |
| Net Profit | $-1.8M | $-2.5M |
| Gross Margin | 34.1% | 43.9% |
| Operating Margin | -13.5% | -3.7% |
| Net Margin | -13.2% | -17.0% |
| Revenue YoY | 15.0% | 79.1% |
| Net Profit YoY | -341.4% | -28.5% |
| EPS (diluted) | — | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $14.5M | ||
| Q3 25 | $12.9M | $12.8M | ||
| Q2 25 | $12.0M | $10.0M | ||
| Q1 25 | $11.7M | $5.1M | ||
| Q4 24 | $11.6M | $8.1M | ||
| Q3 24 | $11.8M | $4.4M | ||
| Q2 24 | $10.0M | $4.5M | ||
| Q1 24 | $9.9M | $3.6M |
| Q4 25 | $-1.8M | $-2.5M | ||
| Q3 25 | $-975.1K | $-3.7M | ||
| Q2 25 | $-362.2K | $-256.7K | ||
| Q1 25 | $-156.2K | $-5.7M | ||
| Q4 24 | $-398.4K | $-1.9M | ||
| Q3 24 | $-166.1K | $-3.2M | ||
| Q2 24 | $-239.1K | $-4.1M | ||
| Q1 24 | $-1.0M | $-9.8M |
| Q4 25 | 34.1% | 43.9% | ||
| Q3 25 | 36.5% | 48.1% | ||
| Q2 25 | 39.9% | 59.1% | ||
| Q1 25 | 41.9% | 21.2% | ||
| Q4 24 | 38.6% | 48.9% | ||
| Q3 24 | 43.0% | 52.8% | ||
| Q2 24 | 41.8% | 31.9% | ||
| Q1 24 | 40.0% | 20.0% |
| Q4 25 | -13.5% | -3.7% | ||
| Q3 25 | -7.7% | -14.3% | ||
| Q2 25 | -3.3% | 1.0% | ||
| Q1 25 | -1.9% | -115.6% | ||
| Q4 24 | -4.1% | -22.7% | ||
| Q3 24 | -2.3% | -73.1% | ||
| Q2 24 | -3.4% | -90.9% | ||
| Q1 24 | -11.0% | -270.3% |
| Q4 25 | -13.2% | -17.0% | ||
| Q3 25 | -7.6% | -29.0% | ||
| Q2 25 | -3.0% | -2.6% | ||
| Q1 25 | -1.3% | -111.0% | ||
| Q4 24 | -3.4% | -23.7% | ||
| Q3 24 | -1.4% | -74.0% | ||
| Q2 24 | -2.4% | -91.8% | ||
| Q1 24 | -10.3% | -270.5% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | — | $-0.02 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.03 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $-0.02 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $3.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $11.5M | $38.2M |
| Total Assets | $19.2M | $74.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $3.2M | ||
| Q3 25 | $5.1M | $5.7M | ||
| Q2 25 | $3.9M | $11.4M | ||
| Q1 25 | $7.0M | $15.9M | ||
| Q4 24 | $8.3M | $466.5K | ||
| Q3 24 | $7.9M | $220.4K | ||
| Q2 24 | $7.6M | $608.2K | ||
| Q1 24 | $7.1M | $948.1K |
| Q4 25 | $11.5M | $38.2M | ||
| Q3 25 | $12.8M | $39.6M | ||
| Q2 25 | $13.4M | $42.0M | ||
| Q1 25 | $13.3M | $40.6M | ||
| Q4 24 | $13.2M | $13.5M | ||
| Q3 24 | $13.1M | $13.7M | ||
| Q2 24 | $12.6M | $14.8M | ||
| Q1 24 | $12.7M | $16.7M |
| Q4 25 | $19.2M | $74.2M | ||
| Q3 25 | $18.9M | $69.6M | ||
| Q2 25 | $20.4M | $70.0M | ||
| Q1 25 | $21.5M | $63.5M | ||
| Q4 24 | $19.3M | $42.4M | ||
| Q3 24 | $18.8M | $39.0M | ||
| Q2 24 | $18.0M | $35.7M | ||
| Q1 24 | $17.6M | $35.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.4K | $-1.5M |
| Free Cash FlowOCF − Capex | — | $-3.2M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 11.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-22.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.4K | $-1.5M | ||
| Q3 25 | $1.2M | $-7.5M | ||
| Q2 25 | $-2.8M | $-3.5M | ||
| Q1 25 | $-1.3M | $-6.1M | ||
| Q4 24 | $339.2K | $-3.3M | ||
| Q3 24 | $305.8K | $-2.5M | ||
| Q2 24 | $642.7K | $-1.0M | ||
| Q1 24 | $-422.3K | $-2.7M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | — | $-8.2M | ||
| Q2 25 | — | $-3.8M | ||
| Q1 25 | — | $-7.0M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | — | $-4.2M | ||
| Q2 24 | — | $-3.1M | ||
| Q1 24 | — | $-2.8M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -64.1% | ||
| Q2 25 | — | -37.7% | ||
| Q1 25 | — | -136.2% | ||
| Q4 24 | — | -41.7% | ||
| Q3 24 | — | -96.9% | ||
| Q2 24 | — | -69.5% | ||
| Q1 24 | — | -76.9% |
| Q4 25 | — | 11.8% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 38.8% | ||
| Q2 24 | — | 46.8% | ||
| Q1 24 | — | 3.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
SSII
| System Sales | $13.4M | 92% |
| Other | $1.2M | 8% |
